
Paushak Q1: revenue leaps ~50% YoY to ₹83.6 Cr, PAT +25% to ₹15.1 Cr as margins slip
specialty chemicals · phosgene · revenue growth
BSE: 532742
P/L Snapshot
Q1 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)
Corporate Events
Board Meeting
The 53rd Annual General Meeting of the Company will be held …
BSE Filing ↗Board Meeting
The Board of Directors approved the Unaudited Financial Resu…
BSE Filing ↗Board Meeting
Considered and approved the resignation of a Whole-time Dire…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results of the Comp…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results
BSE Filing ↗Board Meeting
Proposal of sub-division/split, Proposal for issue of bonus …
BSE Filing ↗Board Meeting
Unaudited Financial Results for the quarter ended on 30‘ Jun…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results for the qua…
BSE Filing ↗Board Meeting
Consider and approve Unaudited Financial Results for the qua…
BSE Filing ↗